Episyringaresinol 4'-O-β-D-glncopyranoside

• CAT Number: I046099
• CAS Number: 137038-13-2
• Molecular Formula: C28H36O13
• Molecular Weight: 580.58
• Purity: ≥95%
• Synonyms: (2S,3R,4S,5S,6R)-2-[4-[(3R,3aS,6R,6aS)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
• InChI: InChI=1S/C28H36O13/c1-34-16-5-12(6-17(35-2)21(16)30)25-14-10-39-26(15(14)11-38-25)13-7-18(36-3)27(19(8-13)37-4)41-28-24(33)23(32)22(31)20(9-29)40-28/h5-8,14-15,20,22-26,28-33H,9-11H2,1-4H3/t14-,15-,20-,22-,23+,24-,25+,26+,28+/m1/s1
• InChIKey: WEKCEGQSIIQPAQ-FKLBZQFOSA-N
• SMILES: COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3CO[C@H]([C@@H]3CO2)C4=CC(=C(C(=C4)OC)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC

Episyringaresinol 4′-O-β-D-glucopyranoside（Cat No.:I046099）is a lignan glycoside isolated from medicinal plants such as Syringa and Forsythia species. It displays diverse pharmacological properties, including antioxidant, anti-inflammatory, hepatoprotective, and anticancer activities. The glucoside moiety enhances solubility and bioavailability, supporting its biological functions. Mechanistically, it modulates oxidative stress responses, regulates inflammatory mediators, and induces apoptosis in tumor cells. Episyringaresinol 4′-O-β-D-glucopyranoside has been investigated for potential roles in liver protection, cancer therapy, and cardiovascular health. As a bioactive natural lignan derivative, it is a valuable compound for pharmacological and therapeutic research.